Physician

Vinay Kumar Puchalapalli Reddy, MD

According to 2025 Medicare claims, Vinay Reddy, MD (NPI: 1275535536) practices rheumatology in the Lake County-Porter County-Jasper County, IN market, with the plurality of this provider's patient population coming from Porter, IN. This provider's primary affiliated billing organization is REDDY RHEUMATOLOGY OF NORTHWEST IN PC (NPI: 1528248242; TIN: 200388567) and primary practice location at 46410-7160. Reddy is affiliated with the Franciscan ACO, Inc. (ACO ID: A2550), IRCCO (ACO ID: A2619), and Main Street Rural Health Cedar ACO LLC (ACO ID: A5502), participating under the MSSP model.

Reddy's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 549 traditional Medicare patients, billed 152,147 HCPCS/CPT codes, and received $2,218,295 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 4,957 prescription claims across 815 beneficiaries totaling $6,279,068 in drug costs, led by Humira(Cf) Pen (Adalimumab). 2023 DME data shows 12 claims. Open Payments data shows 229 records totaling $4,816. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $511,294 to $2,218,295. Similarly, Part D prescription costs have moved sharply higher in recent years, from $2,044,771 to $6,279,068. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $865 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.6M2015 Medicare payment: $511,294 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $922,408 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,768,756 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,812,269 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,156,398 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,359,184 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,044,446 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,635,580 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,687,237 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,218,295 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201594436,456$511,294
201691337,759$922,408
201781963,450$1,768,756
201877268,060$1,812,269
201974089,450$2,156,398
202057388,864$2,359,184
2021587106,583$2,044,446
2022575136,040$2,635,580
2023544120,535$1,687,237
2024549152,147$2,218,295

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$3.2M$6.4M2015 Drug cost: $2,044,771 (USD; Tot_Drug_Cst)2016 Drug cost: $2,147,892 (USD; Tot_Drug_Cst)2017 Drug cost: $2,317,331 (USD; Tot_Drug_Cst)2018 Drug cost: $3,400,876 (USD; Tot_Drug_Cst)2019 Drug cost: $3,193,275 (USD; Tot_Drug_Cst)2020 Drug cost: $3,664,238 (USD; Tot_Drug_Cst)2021 Drug cost: $4,031,386 (USD; Tot_Drug_Cst)2022 Drug cost: $5,151,806 (USD; Tot_Drug_Cst)2023 Drug cost: $6,390,864 (USD; Tot_Drug_Cst)2024 Drug cost: $6,279,068 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20157749,442$2,044,771
20168138,814$2,147,892
20178158,985$2,317,331
20188238,690$3,400,876
20197897,962$3,193,275
20207026,681$3,664,238
20217355,434$4,031,386
20227685,330$5,151,806
20238065,249$6,390,864
20248154,957$6,279,068

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$18K$35K2015 Medicare payment: $35,085 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $18,389 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $32,161 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $22,539 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $34,327 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $13,438 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $11,015 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
20153849$35,085
20162224$18,389
20175555$32,161
20184345$22,539
20195557$34,327
2020N/RN/RN/R
2021N/RN/RN/R
20222626$13,438
20231212$11,015
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more8484$107
96413Administration of chemotherapy into vein, 1 hour or less65460$87
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more263372$79
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more408750$60
82306Vitamin d-3 level123128$28

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab1825,576$1,361,474
Enbrel SureclickEtanercept1584,452$1,178,852
RinvoqUpadacitinib742,280$489,102
Orencia ClickjectAbatacept772,324$475,460
EnbrelEtanercept551,652$451,335

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.229$4,816Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Vinay Kumar Puchalapalli Reddy, MD?

Tedicare shows public-source Medicare data for Vinay Kumar Puchalapalli Reddy, MD (NPI 1275535536), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vinay Kumar Puchalapalli Reddy, MD have ACO affiliation data?

Vinay Kumar Puchalapalli Reddy, MD is shown with ACO affiliation data for Franciscan ACO, Inc. (MSSP, ACO ID A2550), IRCCO (MSSP, ACO ID A2619), and Main Street Rural Health Cedar ACO LLC (MSSP, ACO ID A5502).

What billing organization is linked to Vinay Kumar Puchalapalli Reddy, MD?

Vinay Kumar Puchalapalli Reddy, MD is linked to REDDY RHEUMATOLOGY OF NORTHWEST IN PC (billing NPI 1528248242) in the available physician profile data.

Does Vinay Kumar Puchalapalli Reddy, MD have Open Payments data?

Vinay Kumar Puchalapalli Reddy, MD has 229 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.